BVS logo

BVS Bioventus Inc.

NASDAQ · Medical - Devices · Healthcare

$9.88
-0.07 (-0.70%)

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis;…

Market Cap: $676.53Mwww.bioventus.com

Price

No data yet.

Social Signal Score

54
5d
—
30d
54
5 mentions
—
60d
54
5 mentions
—
90d
55
6 mentions
—
news: 6

Analyst Ratings

7 analysts
Buyconsensus
Strong Buy 0Buy 5Hold 2Sell 0Strong Sell 0
Avg price target$18.33+85.5%
Low $18Median $18High $19
Current Consensus

Revenue

$142.44M+166.94%
$53.36M$88.21M$123.05M$157.90M
Mar 2015Sep 2026

Analyst Estimates

FY2025
$0.66
$0.65–$0.67
2 analysts
FY2026
$0.77+16% YoY
$0.76–$0.78
4 analysts
FY2027
$0.88+15% YoY
$0.85–$0.90
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Robert Claypoole
Sector
Healthcare
Industry
Medical - Devices
Employees
960
Beta
0.62
Country
US
Piotroski score
7 / 9 (Strong)
Altman Z-score
1.80
www.bioventus.com